Fortrea (NASDAQ:FTRE) Announces Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Fortrea (NASDAQ:FTRE) released its quarterly earnings data on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.13, FiscalAI reports. Fortrea had a negative net margin of 36.21% and a positive return on equity of 6.23%. The firm had revenue of $636.50 million during the quarter, compared to analysts’ expectations of $627.42 million.

Here are the key takeaways from Fortrea’s conference call:

• Fortrea reported a solid Q1 with adjusted EBITDA of $47M, improved adjusted net income ($15.2M) and reiterated full‑year guidance of $2.55B–$2.65B revenue and $190M–$220M adjusted EBITDA, supporting the company’s path back to profitability.
• Commercial momentum improved: Q1 book‑to‑bill was 1.15x (1.05x TTM), with stronger biotech wins, more RFPs (including new‑to‑Fortrea biotechs), and double‑digit growth in the China pipeline.
• Management launched Fortrea Intelligent Technology (FIT), an AI/ML platform integrated into Xcellerate, receiving positive early feedback but described as “early days” with uncertain near‑term financial impact.
• Rightsizing produced ~$16M gross (~$9M net) of quarterly savings and management reiterated a multi‑year target to reach mid‑teens adjusted EBITDA margin over 3–5 years, driven by cost optimization and revenue diversification.
• Cash and liquidity improved materially: Q1 operating cash flow was negative $17M (much better than prior year) and available liquidity exceeds $0.5B, with no revolver usage in the quarter.

Fortrea Stock Up 4.2%

NASDAQ FTRE traded up $0.61 on Wednesday, hitting $15.14. 433,673 shares of the stock were exchanged, compared to its average volume of 1,571,130. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.86. Fortrea has a fifty-two week low of $3.97 and a fifty-two week high of $18.67. The company has a market cap of $1.43 billion, a PE ratio of -1.39, a PEG ratio of 0.46 and a beta of 1.92. The company has a 50-day moving average price of $9.95 and a 200-day moving average price of $12.50.

Insider Buying and Selling

In other Fortrea news, CFO Jill G. Mcconnell sold 5,061 shares of the business’s stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $9.07, for a total transaction of $45,903.27. Following the completion of the transaction, the chief financial officer owned 69,796 shares in the company, valued at $633,049.72. The trade was a 6.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In the last ninety days, insiders have sold 9,673 shares of company stock worth $92,242. Insiders own 0.38% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its holdings in Fortrea by 494.8% during the 2nd quarter. AQR Capital Management LLC now owns 6,515,124 shares of the company’s stock worth $31,729,000 after acquiring an additional 5,419,842 shares in the last quarter. State Street Corp lifted its position in shares of Fortrea by 1.0% during the 4th quarter. State Street Corp now owns 4,110,899 shares of the company’s stock worth $70,913,000 after buying an additional 39,777 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Fortrea by 21.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,219,029 shares of the company’s stock worth $55,528,000 after buying an additional 565,891 shares during the last quarter. Deutsche Bank AG lifted its position in shares of Fortrea by 0.3% during the 4th quarter. Deutsche Bank AG now owns 2,556,193 shares of the company’s stock worth $44,094,000 after buying an additional 7,685 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Fortrea by 9.4% during the 4th quarter. Geode Capital Management LLC now owns 2,278,934 shares of the company’s stock worth $39,318,000 after buying an additional 196,759 shares during the last quarter.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Evercore set a $25.00 target price on Fortrea and gave the company an “outperform” rating in a research report on Tuesday, January 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Fortrea in a research report on Tuesday, April 21st. TD Cowen reissued a “buy” rating on shares of Fortrea in a research report on Wednesday. Mizuho set a $15.00 price objective on shares of Fortrea in a report on Friday, January 9th. Finally, Citigroup restated a “buy” rating on shares of Fortrea in a report on Wednesday. Five research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $16.95.

Key Headlines Impacting Fortrea

Here are the key news stories impacting Fortrea this week:

• Positive Sentiment: Q1 EPS beat — Fortrea reported $0.16 EPS vs. a $0.03 consensus, comfortably topping estimates and signaling improving profitability trends. Read More.
• Positive Sentiment: Revenue beat — Q1 revenue came in at $636.5M versus ~ $627.4M expected, supporting the EPS beat and showing demand momentum. Read More.
• Positive Sentiment: Guidance and demand signal — Management reiterated/updated FY2026 revenue guidance around $2.6–$2.7B and highlighted a book-to-bill of 1.15x (third consecutive quarter above 1.1x), which supports forward revenue visibility. Read More.
• Neutral Sentiment: Earnings call & transcripts available — Management commentary and the full Q&A are now posted (useful for gauging booking cadence, margins and client trends). Read More.
• Neutral Sentiment: Investor materials published — Slide deck and conference-call recording are posted for deeper review of segment performance and backlog. Read More.
• Negative Sentiment: Profitability still a concern — Despite the EPS beat, Fortrea reported a negative net margin (~-36%) and remains unprofitable on that measure, which could cap rerating until margins sustainably improve. Read More.
• Negative Sentiment: Balance-sheet & valuation risks — Leverage (debt/equity ~1.86), current ratio under 1, negative P/E and elevated beta increase investor risk profile despite the beat. These metrics could pressure the stock if growth or margin improvement slows. Read More.

About Fortrea

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.